Reply: Did animal offer relevant model for bevacizumab testing?

被引:0
作者
A Bozec
A Sudaka
J L Fischel
M C Brunstein
M C Grimaldi
G Milano
机构
[1] Centre Antoine Lacassagne,
[2] Oncopharmacology Unit,undefined
[3] Pathology Laboratory,undefined
[4] Centre Antoine Lacassagne,undefined
来源
British Journal of Cancer | 2008年 / 99卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1556 / 1556
相关论文
共 11 条
[1]  
Bozec A(2008)Vertical VEGF targeting: a combination of ligand blockade with receptor tyrosine kinase inhibitor Eur J Cancer 42 1922-1930
[2]  
Gros FX(2005)Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies Cancer Res 65 671-680
[3]  
Penault-Llorca F(undefined)undefined undefined undefined undefined-undefined
[4]  
Formento P(undefined)undefined undefined undefined undefined-undefined
[5]  
Cayre A(undefined)undefined undefined undefined undefined-undefined
[6]  
Dental C(undefined)undefined undefined undefined undefined-undefined
[7]  
Etienne-Grimaldi MC(undefined)undefined undefined undefined undefined-undefined
[8]  
Fischel JL(undefined)undefined undefined undefined undefined-undefined
[9]  
Milano G(undefined)undefined undefined undefined undefined-undefined
[10]  
Gerber HP(undefined)undefined undefined undefined undefined-undefined